Date post: | 31-Dec-2015 |
Category: |
Documents |
Upload: | chanda-roberts |
View: | 20 times |
Download: | 3 times |
Treatment Advances in Achieving Remission in Mild to
Moderate Ulcerative Colitis
Goals of Therapy for Patients With UC
Sequential Therapies for UC
Oral 5-ASA Formulations: Sites of Delivery
Conventional Corticosteroids in UC
Corticosteroids: Dependency—Short- and Long-term Efficacy
CORE I and II: Budesonide MMX Primary End Point: Combined Clinical and Endoscopic
Remission
Azathioprine vs 5-ASA for Corticosteroid-Dependent, Active
UC
Anti-TNF Therapies for Moderate to Severe Disease
Treatment Algorithm to Maximize Remission and Minimize
Corticosteroid Dependence in UC
Patient Case
Mesalamine Safety
Patient Case (cont)
Pooled Safety Data: Adverse Effects of Budesonide MMX in Patients With Active UC
Anti-TNF Agents: Adverse Events
Minimizing Toxicity for Anti-TNF Therapy
Summary: Safety
Effect on Bone Density
Monitoring the Patient Receiving Budesonide MMX
Summary: Safety of Agents Used to Induce Remission in Mild to
Moderate UC
Abbreviations
References
References (cont)
References (cont)